Merck (NYSE:MRK) shares fell nearly 8% Tuesday premarket after the pharma giant issued an outlook for the year that fell short of Wall Street estimates and said it is temporarily pausing shipments ...
Merck (MRK) reported fourth quarter and full-year earnings Tuesday, in line with Wall Street estimates. The bad news: Its stock was down more than 10% in early trading, largely because of weaker ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback